The pharmaceutical industry is expanding rapidly due to the rise in sales of drugs and therapies. This growth is driven by the growing prevalence of chronic diseases and an increasing elderly population, coupled with increased healthcare spending.
Given the pharmaceutical industry’s growth prospects, long-term value investors could look to buy fundamentally strong pharma stocks Organon & Co. (OGN), Procaps Group S.A. (PROC), Johnson & Johnson (JNJ), and GSK plc (GSK), trading at a discount.
